PRECISION BIOSCIENCES INC
For the period ended Mar 31, 2025. Filed May 15, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 15, 2025
DTIL$10.60+7.4%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Statements of Operations
(In thousands, except share and per share amounts)
| For the Three Months Ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Revenue | $29 | $17,584 |
| Operating expenses | ||
| Research and development | 13,588 | 13,343 |
| General and administrative | 8,553 | 8,428 |
| Total operating expenses | 22,141 | 21,771 |
| Operating loss | (22,112) | (4,187) |
| Other income (expense): | ||
| Gain from equity method investment | 1,342 | 1,713 |
| Gain (loss) on changes in fair value | 49 | (348) |
| (Loss) gain on change in fair value of warrant liability | (804) | 10,386 |
| Interest expense | (354) | (574) |
| Interest income | 1,323 | 1,663 |
| Loss on disposal of assets | (9) | (65) |
| Total other income | 1,547 | 12,775 |
| (Loss) income from operations | $(20,565) | $8,588 |
| Net (loss) income | $(20,565) | $8,588 |
| Net (loss) income per share | ||
| Basic | $(2.21) | $1.70 |
| Diluted | $(2.21) | $1.70 |
| Weighted-average shares of common stock outstanding | ||
| Basic | 9,292,066 | 5,060,978 |
| Diluted | 9,292,066 | 5,063,406 |
Condensed Statements of Changes in
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.